Antibody vaccine conjugates and uses therefor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9259459
APP PUB NO 20050180983A1
SERIAL NO

10903191

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides novel antibody vaccine conjugates and methods of using the same to induce a cytotoxic T cell (CTL) response. In a particular, embodiment, the vaccine conjugate includes a human chorionic gonadotropin beta subunit (βhCG) antigen linked to an anti-mannose receptor (MR) antibody.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CELLDEX THERAPEUTICS INC119 FOURTH AVENUE NEEDHAM MA 02494-2725

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Endres, Michael Riegelsville, US 19 140
He, Lizhen Allentown, US 27 308
Keler, Tibor Ottsville, US 53 897
Ramakrishna, Venky Riegelsville, US 11 289

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 16, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00